Skip to main content

Posterior segment complications of Ahmed valve implantation

Abstract

Background

To assess the time, incidence, and outcome of posterior segment complications of Ahmed valve implantation (AVI).

Methods

248 eyes that underwent AVI were reviewed retrospectively. Visual acuity, preoperative characteristics, and postoperative posterior segment complications were assessed.

Results

The incidence of posterior segment complications of AVI was 31.4% (78/248). The mean follow-up period was 97.4 ± 53.5 months. The mean time to occur posterior segment complication was 1.5 months. The most common posterior segment complication was choroidal detachment (17.7%) and others included ocular decompression retinopathy (3.2%), hypotonic maculopathy (2.8%), vitreous hemorrhage (2.0%), retinal detachment (1.2%), endophthalmitis (1.2%), suprachoroidal hemorrhage (1.2%), epiretinal membrane (0.8%), cystoid macular edema (0.8%), and proliferative vitreoretinopathy (0.4%). Older age, hypertension, and postoperative hypotony had an increased risk of posterior segment complications of AVI.

Conclusions

The overall incidence of posterior segment complications of AVI was 31.4%. Older age, hypertension, and postoperative hypotony were significantly associated with posterior segment complications of AVI.

Peer Review reports

Background

The purpose of the glaucoma surgery is to decrease intraocular pressure (IOP) by producing a new aqueous humor outflow pathway, and hence avoid further damage of optic nerve. In contrast to trabeculectomy, Ahmed valve implantation (AVI) yields a different drainage pathway of aqueous humor bypassing dysfunctional anterior chamber angle [1]. It has been a vital technique for refractory glaucoma after multiple failed surgeries. The aqueous shunt has been used increasingly in the treatment of medically uncontrolled glaucoma and it is becoming more common to utilize glaucoma drainage implants for refractory glaucoma [2]. In 2008 American Glaucoma Society survey there was a important alteration in treatment pattern, showing that the use of trabeculectomy was decreased from 81 to 46% and the use of glaucoma drainage device was increased from 18 to 51% [3]. The stimulus for the diversion could be grounded on the outcomes of the Tube Versus Trabeculectomy (TVT) study [4, 5]. However, the elucidation of the outcome is confounded by the intricacy of study design [6].

The aim of our study is to describe time, incidence, and outcomes of posterior segment complications of AVI, so as to allow relevant management to be conducted after AVI.

Methods

Our study adhered to the tenets of the Declaration of Helsinki and was approved by the Institutional Review Board of Dankook university hospital (IRB#DKUH202010033). The medical records of patients who were treated with AVI to control intractable IOP elevation from January, 2004 through August, 2020 were reviewed retrospectively. Patients with post-operative follow-up period > 36 months, IOP remained higher than 21 mmHg even after using glaucoma medications, and without mental illness were included. Only one eye was recruited from a single patient. Patients with concomitant treatments, such as silicone oil removal, penetrating keratoplasty, or cataract extraction during AVI were excluded.

Data were collected before and after AVI including known medical and ocular history, age, previous posterior segment disease, indication for surgery, number of AVI, best corrected visual acuity (BCVA), IOP, postoperative posterior segment complications, and medical or surgical interventions during the follow-up time. The patients were evaluated preoperatively, at postoperative 1 day, 1, 2 week, 1, 2, 3, 6 months, and thereafter yearly and were assessed by slit-lamp biomicroscopy, gonioscopy, funduscopy, Goldmann applanation tonometry at each visit. Standard automated perimetry (Humphrey Visual Field Analyzer; Carl Zeiss-Meditec Inc., Dublin, CA, USA), optical coherence tomography (OCT, Carl zeiss, Jena, Germany), and color disc photography (FF450 with Visupac, Carl Zeiss Meditec) were used to evaluate glaucoma control. IOP reading was examined 3 times to calculate the average value. Visual acuity (VA) was measured with Hahn’s visual acuity chart (Hahn’s Co. Ltd., Seoul, Korea) placed 5 m from the subject. The original data for BCVA was collected in Snellen values and converted to LogMAR for statistical analysis. Postoperative posterior segment complications of AVI were defined as any pathologic lesion which was not present before AVI located on the posterior segment and diagnosed with clinical fundus examination, B scan ultrasonography, or OCT.

Ahmed valve implantation

Ahmed valves model FP7 (New World Medical, Rancho Cucamonga, California, USA) were used during all operations. Fornix-based incision was created through tenon capsule and conjunctiva. After priming the valve, the body was inserted and secured to the sclera 8 mm posteriorly from corneoscleral limbus (Fig. 1). The tube was cut and placed into anterior chamber. A sclera patch was sutured to cover the valve on sclerostomy site and the tenon and conjunctiva was approximated. Topical antibiotics and steroids were used after AVI.

Fig. 1
figure 1

Intraoperative image of Ahmed valve implantation

Statistical analysis

The categorical variables were compared by a chi square test. t test was used to compare the data of patients with posterior segment complications and those without. The factors associated with the posterior segment complications of AVI were evaluated by multivariate Cox proportional hazard regression. SPSS statistical software (version 19.0; SPSS Science Inc., Chicago, IL, USA) was used and p values less than 0.05 were deemed statistically significant.

Results

248 eyes of 248 patients who underwent AVI were included. The patients were 132 (53.2%) men and 116 (46.8%) women, and the mean age was 65.7 ± 11.6 years. The mean follow-up time was 97.4 ± 53.5 months. The indications for AVI were 102 (41.1%) cases of neovascular glaucoma, 51 (20.6%) cases of uveitic glaucoma, 23 (9.3%) cases of pseudoexfoliative glaucoma, 40 (16.1%) cases of primary open angle glaucoma, and 32 (12.9%) cases of other secondary glaucoma (Table 1).

Table 1 Demographic characteristics of patients who underwent Ahmed valve implantation

78 eyes (31.4%) showed posterior segment complication after AVI. The mean time of occurring posterior segment complications was 1.5 months. Table 2 shows BCVA and IOP between eyes with posterior segment complications and those without. Before AVI, no significant difference was shown in the mean preoperative BCVA (logMAR ± SD: 0.7 ± 0.4, 0.6 ± 0.3, respectively, p = 0.61), but, the mean final postoperative BCVA was significantly worse in eyes with posterior segment complications compared to the eyes without (logMAR ± SD: 1.4 ± 0.5, 0.7 ± 0.3, respectively p = 0.004). In 78 eyes with posterior segment complications, 85.8% had postoperative hypotony (IOP < 6 mmHg) on one or more postoperative evaluations for 2 to 35 days. Patients presenting with hypertension had an elevated hazard ratio (HR) of 1.63 (95% confidence interval [CI] 1.05–2.73, p = 0.004). There was an increased risk of posterior segment complications for patients with postoperative hypotony (HR 6.52, 95% CI 1.83–21.45, p = 0.002). Older age had an elevated HR of 1.35 (95% CI 0.97–2.05, p = 0.004). Patients presenting with diabetes had HR of 1.27 (95% CI 0.69–1.93, p = 0.076). Higher mean preoperative IOP had HR of 1.14 (95% CI 0.53–2.16, p = 0.083).

Table 2 Comparison between eyes with and without posterior segment complications of Ahmed valve implantation

The incidence of posterior segment complications of AVI is summarized in Table 3. The most common posterior segment complication was choroidal detachment (44 eyes; 17.7%), followed by ocular decompression retinopathy (8 eyes; 3.2%), hypotonic maculopathy (7 eyes; 2.8%), vitreous hemorrhage (5 eyes; 2.0%), endophthalmitis (3 eyes; 1.2%), retinal detachment (3 eyes; 1.2%), suprachoroidal hemorrhage (3 eyes; 1.2%), cystoid macular edema (2 eyes; 0.8%), epiretinal membrane (2 eyes; 0.8%), and proliferative vitreoretinopathy (1 eye; 0.4%). The majority of choroidal detachment, ocular decompression retinopathy, and suprachoroidal hemorrhage developed within postoperative 1 month, but most cases of epiretinal membrane and retinal detachment were revealed after postoperative 3 months.

Table 3 Postoperative posterior segment complications and interventions after Ahmed valve implantation

Choroidal detachment occurred in the first postoperative week mostly and was resolved with observation. Vision was improved after resolution. Ocular decompression retinopathy was resolved in around 2 to 12 weeks. A central scotoma was noted while most of the cases were asymptomatic. No intervention was needed. Hypotonic maculopathy was treated with contact lens tamponade, pressure patching, or wound revision and resuturing.

Early infection occurred within the first month of the surgery, and late cases occurred years after the surgery and were because of the tube exposure. A patient underwent immediate vitrectomy and removal of the implant with vitreous sampling for culture, intravitreal vancomycin and ceftazidime injection. They were managed by intensive topical and systemic antibiotics. The culture of scleral patch of one patient was positive for staphylococcus species. In other patients, cultures grew streptococcus pneumonia and extensive retinal necrosis was the main operative finding.

High preoperative IOP, high myopia, anticoagulation, and systemic hypertension were attributed in most cases of suprachoroidal hemorrhage. Two patients had coughing after AVI and a small suprachoroidal hemorrhage was documented. It was confined to 1 or 2 quadrants so they were treated with conservative management with systemic steroids. One patient had a 360° appositional suprachoroidal hemorrhage after severe coughing that was documented on postoperative day 11 and drainage was performed with vitrectomy after 10 days following the liquefaction of suprachoroidal hemorrhage.

One serous retinal detachment didn’t require intervention. The other two eyes showed rhegmatogenous retinal detachment and required vitrectomy. The retina was attached after vitrectomy.

Four eyes with isolated vitreous hemorrhages were spontaneously resolved and one case underwent vitrectomy because vitreous hemorrhage compromised the shunt outflow resulting in increased IOP. In three patients, the tube was occluded by clot and hyphema from postoperative days 1 to 6. The eyes with cystoid macular edema were treated with intravitreal bevacizumab or triamcinolone and multiple injections were needed in one eye. The patient with proliferative vitreoretinopathy underwent vitrectomy but, resulted in phthisis bulbi, maintained VA to light perception.

Discussion

Glaucoma drainage implants are shown to be successful in IOP reduction. When target IOP is not achievable with medical therapy or laser, glaucoma drainage implants should be chosen especially in secondary glaucoma in spite of the risk of complication because glaucoma ends up in irreversible blindness.

Although IOP can be successfully managed after AVI, posterior segment complications may develop. It is significant to understand the possible postoperative complications of AVI to maximize surgical efficacy. However, posterior segment complications of AVI have not been described in detail previously. In previous studies, rates of retinal complications were from 14 to 50% for the Molteno implant, 35% for the Krupin-Denver valve, 38–40% for the Krupin valve with a disc, and 22–48% for the Baerveldt implant [7,8,9]. Comparing these studies is hard due to different follow-up periods, different patient populations, small sample size, different surgical techniques, and different criteria for diagnosis. Our study involved a large sample size of eyes and the incidence of posterior segment complications of AVI was 31.4%.

The TVT study compared the efficacy of glaucoma drainage implant to trabeculectomy [4, 5]. The rate of postoperative complications was 34% during the first year which was similar to our study. The cumulative probability of failure was 29.8% in the tube group at 5 years [4, 5]. However since the Baerveldt implant was used in the TVT study, it’s difficult to accurately compare the results with ours. In the Ahmed Baerveldt Comparison Study, hyphema was the most common complication, accounting for 79% of intraoperative complications and no patient suffered an intraoperative suprachoroidal hemorrhage [10]. In the Ahmed Versus Baerveldt study, the complication rate was 52% in the Ahmed group which was higher than our results. The choroidal effusions accounted for 13%, which is similar to our study [11, 12].

Choroidal detachment, which also accounted for large proportion of posterior segment complication in our study, the incidence was 17.7%. In the TVT study, the incidence of choroidal effusion was 14% in tube which was similar to our results [5]. Another study reported 10% of choroidal effusion in Baerveldt valves and 15% in Ahmed valves [13]. The reported incidence of hypotonic maculopathy is 1.3–20% after glaucoma surgery [14]. We showed 2.0% of postoperative vitreous hemorrhage after AVI. Vitreous hemorrhage might have been a complication of the AVI, although contribution of underlying conditions could not be perfectly ruled out. Law et al. showed 5% incidence of vitreous hemorrhage after aqueous shunt placement [15]. The hemorrhage may result from, deep sclera sutures, bleeding from posterior segment conditions like suprachoroidal hemorrhage, or extension of bleeding from shunt entrance wound and iris neovascularization.

The reported incidence of suprachoroidal hemorrhage is 0.6–1.5% after trabeculectomy and 0.5–8.3% after shunt procedures [16]. In our study, intraoperative and delayed suprachoroidal hemorrhage was recognized in 1.2% which was similar with previous studies. Risk factors are high myopia, severe postoperative hypotony, high preoperative IOP, pseudophakia, aphakia, pulmonary disease, ischemic heart disease, systemic hypertension, and anticoagulation [17]. In our study, patients informed of their coughing prior to the onset of suprachoroidal hemorrhage. The visual prognosis was seriously bad, therefore, managing IOP, controlling risk factors, and monitoring of INR can decrease the risk for suprachoroidal hemorrhages after AVI.

The reported incidence of infectious disease after glaucoma surgery is 0.12–1.3% for endophthalmitis, 0.55–2.6% for blebitis [18, 19]. The endophthalmitis after AVI was reported to show more insidious onset than after cataract surgery and late-onset cases may develop after months to years due to infection through tube exposure [20]. Bacterial strains in endophthalmitis after AVI were reported to be more virulent, and showed high percentage of streptococcus species [21]. The incidence of retinal detachment was 1.2% in our study. Previous study revealed 5% incidence of retinal detachment after Molteno implant surgery, developing within 4 months following surgery [22].

Mermound et al. and Sidoti et al. found that preoperative VA worse than 20/200, diabetic retinopathy as cause of neovascularization, and young age were significantly associated with surgical failure for neovascular glaucoma in Molteno and Baerveldt shunt surgery [23, 24]. However, those authors did not separately assess IOP control and visual acuity in patients with posterior segment complications. In our study, older age, postoperative hypotony, and hypertension were found to be associated with posterior segment complications of AVI. Hypertension increases the fragility of vasculature and disrupts the integrity of the choroidal vasculature, that eventually lead to increased permeability [25, 26]. The structural vulnerability of the microvasculature, intraoperative or postoperative blood flow fluctuation may result in posterior segment complications in the old aged patients. The hypotony in postoperative period contributes to choroidal effusion and it causes a mechanical stress on the posterior ciliary artery which may result in suprachoroidal hemorrhage [27, 28]. Haga et al. showed that older age and postoperative hypotony were risk factors for choroidal detachment [29]. The results shown in our study are consistent with previous studies.

This limitation of our study is that the study was conducted by a retrospective design. However, we reported the most significant representation of postoperative posterior segment complications of AVI, both in regards to duration of follow-up and number of eyes. Our study quantified the long-term complication rates that can reshape surgical armamentarium and improve the quality of treatment of glaucoma.

Conclusions

The overall incidence of posterior segment complications of AVI was 31.4%. Older age, hypertension, and postoperative hypotony were significantly associated with posterior segment complications of AVI.

Availability of data and materials

The datasets used and/or analysed during the current study are available from the corresponding author on reasonable request.

Abbreviations

BCVA:

Best corrected visual acuity

IOP:

Intraocular pressure

LogMAR:

Logarithm of the minimum angle of resolution

OCT:

Optical coherence tomography

SD:

Standard deviation

VA:

Visual acuity

References

  1. Moss EB, Trope GE. Assessment of closing pressure in silicone Ahmed FP7 glaucoma valves. J Glaucoma. 2008;17:489–93.

    Article  Google Scholar 

  2. Ayyala RS, Duarte JA, Sahiner N. Glaucoma drainage devices: state of the art. Expert Rev Med Devices. 2006;3:509–26.

    Article  Google Scholar 

  3. Desai MA, Gedde SJ, Feuer WJ, et al. Practice preferences for glaucoma surgery: a survey of the American Glaucoma Society in 2008. Ophthalmic Surg Lasers Imaging. 2011;42:202–8.

    Article  Google Scholar 

  4. Gedde SJ, Schiffman JC, Feuer WJ, et al. Treatment outcomes in the tube versus trabeculectomy (TVT) study after five years of follow-up. Am J Ophthalmol. 2012;153:789–803.

    Article  Google Scholar 

  5. Gedde SJ, Herndon LW, Brandt JD, et al. Postoperative complications in the tube versus trabeculectomy (TVT) study during five years of follow-up. Am J Ophthalmol. 2012;153:804–14.

    Article  Google Scholar 

  6. Caprioli J. The tube versus trabeculectomy study: why its findings may not change clinical practice? Am J Ophthalmol. 2011;151:742–4.

    Article  Google Scholar 

  7. Melamed S, Cahane M, Gutman I, Blumenthal M. Postoperative complications after Molteno implant surgery. Am J Ophthalmol. 1991;111:319–22.

    CAS  Article  Google Scholar 

  8. Krupin T, Ritch R, Camras CB, Brucker AJ, Muldoon TO, Serle J, et al. A long Krupin-Denver valve implant attached to a 180-degree scleral explant for glaucoma surgery. Ophthalmology. 1988;95:1174–80.

    CAS  Article  Google Scholar 

  9. The Krupin Eye Valve Filtering Surgery Study Group. Krupin eye valve with disk for filtering surgery. Ophthalmology. 1994;101:651–8.

    Article  Google Scholar 

  10. Barton K, Gedde SJ, Budenz DL, Feuer WJ, Schiffman J. The Ahmed Baerveldt comparison (ABC) study: methodology, baseline patient characteristics and intraoperative complications. Ophthalmology. 2011;118:435–42.

    Article  Google Scholar 

  11. Christakis PG, Tsai JC, Kalenak JW, et al. The Ahmed versus Baerveldt study: three-year treatment outcomes. Ophthalmology. 2013;120:2232–40.

    Article  Google Scholar 

  12. Christakis PG, Kalenak JW, Tsai JC, Zurakowski D, Kammer JA, Harasymowycz PJ, et al. The Ahmed versus Baerveldt study: five-year treatment outcomes. Ophthalmology. 2016;123:2093–102.

    Article  Google Scholar 

  13. Budenz DL, Barton K, Feuer WJ, Schiffman J, Costa VP, Godfrey DG, et al. Treatment outcomes in the Ahmed Baerveldt comparison study after 1 year of follow-up. Ophthalmology. 2011;118:443–52.

    Article  Google Scholar 

  14. Fannin LA, Schiffman JC, Budenz DL. Risk factors for hypotony maculopathy. Ophthalmology. 2003;110:1185–91.

    Article  Google Scholar 

  15. Law SK, Kalenak JW, Connor TB, Pulido JS, Han DP, Mieler WF. Retinal complications after aqueous shunt surgical procedures for glaucoma. Arch Ophthalmol. 1996;114:1473–80.

    CAS  Article  Google Scholar 

  16. Vaziri K, Schwartz SG, Kishor KS, Fortun JA, Moshfeghi DM, Moshfeghi AA, et al. Incidence of postoperative suprachoroidal hemorrhage after glaucoma filtration surgeries in the United States. Clin Ophthalmol. 2015;9:579.

    PubMed  PubMed Central  Google Scholar 

  17. Speaker MG, Guerriero PN, Met JA, Coad CT, Berger A, Marmor M. A case-control study of risk factors for intraoperative suprachoroidal expulsive hemorrhage. Ophthalmology. 1991;98:202–9.

    CAS  Article  Google Scholar 

  18. Vaziri K, Kishor K, Schwartz SG, Maharaj AS, Moshfeghi DM, Moshfeghi AA, et al. Incidence of bleb-associated endophthalmitis in the United States. Clin Ophthalmol. 2015;9:317.

    PubMed  PubMed Central  Google Scholar 

  19. Muckley ED, Lehrer RA. Late-onset blebitis/endophthalmitis: incidence and outcomes with mitomycin C. Optom Vis Sci. 2004;81:499–504.

    Article  Google Scholar 

  20. Lemley CA, Han DP. Endophthalmitis: a review of current evaluation and management. Retina. 2007;27:662–80.

    Article  Google Scholar 

  21. Phillips WB 2nd, Wong TP, Bergren RL, Friedberg MA, Benson WE. Late-onset endophthalmitis associated with filtering blebs. Ophthalmic Surg. 1994;25:88–91.

    PubMed  Google Scholar 

  22. Waterhouse WJ, Lloyd MA, Dugel PU, Heuer DK, Baerveldt G, Minckler DS, et al. Rhegmatogenous retinal detachment after Molteno glaucoma implant surgery. Ophthalmology. 1994;101:665–71.

    CAS  Article  Google Scholar 

  23. Mermound A, Salmon JF, Alexander P, Straker C, Murray AD. Molteno tube implantation for neovascular glaucoma: long-term results and factors influencing the outcome. Ophthalmology. 1993;100:897–902.

    Article  Google Scholar 

  24. Sidoti PA, Dunphy TR, Baerveldt G, LaBree L, Minckler DS, Lee PP, et al. Experience with the Baerveldt glaucoma implant in treating neovascular glaucoma. Ophthalmology. 1995;102:1107–18.

    CAS  Article  Google Scholar 

  25. Chu TG, Green RL. Suprachoroidal hemorrhage. Surv Ophthalmol. 1999;43:471–86.

    CAS  Article  Google Scholar 

  26. Saxena RC, Kumar D. Choroidal detachment (a clinic-aetiopathological study). Indian J Ophthalmol. 1983;31:238–41.

    CAS  PubMed  Google Scholar 

  27. Lotufo DG. Postoperative complications and visual loss following Molteno implantation. Ophthalmic Surg. 1991;22:650–6.

    CAS  PubMed  Google Scholar 

  28. Wolter JR, Garfinkel RA. Cilioretinal effusion as precursor of suprachoroidal hemorrhage: a pathological study. Ophthalmic Surg. 1988;19:344–9.

    CAS  PubMed  Google Scholar 

  29. Haga A, Inatani M, Shobayashi K, Kojima S, Inoue T, Tanihara H. Risk factors for choroidal detachment after trabeculectomy with mitomycin C. Clin Ophthalmol. 2013;7:1417–1.

    PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

Not applicable.

Funding

The present research was supported by the research fund of Dankook University in 2020.

The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Author information

Authors and Affiliations

Authors

Contributions

Study concept and design (YP); collection, management, analysis, and interpretation of data (YP); and preparation, review, or approval of the manuscript (KJC,YP). All authors read and approved the final manuscript.

Corresponding author

Correspondence to Kyong Jin Cho.

Ethics declarations

Ethics approval and consent to participate

Our study adhered to the tenets of the Declaration of Helsinki for research involving human subjects and followed all guidelines for investigation in human subjects required and approved by the Institutional Review Board of Dankook university hospital (IRB#DKUH202010033). The records of all patients who underwent AVI from January, 2004 through August, 2020 were retrospectively reviewed. Administrative permission to use the data was provided by the Institutional Review Board of Dankook university hospital (IRB#DKUH202010033). Informed consent was waived by the Institutional Review Board of Dankook university hospital because of the study’s retrospective nature.

Consent for publication

Not applicable.

Competing interests

The authors declare that we have no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Park, Y., Cho, K.J. Posterior segment complications of Ahmed valve implantation. BMC Ophthalmol 22, 78 (2022). https://doi.org/10.1186/s12886-022-02297-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12886-022-02297-y

Keywords

  • Ahmed valve implantation
  • Posterior segment complication